Aplastic Anemia
-
News
APLASTIC ANEMIA | Hetrombopag Achieves Significant Hematological Responses in Newly Diagnosed Patients
In this study, newly diagnosed patients with transfusion-dependent non-severe aplastic anemia (TD-NSAA) were initially treated with either a combination of cyclosporin A (CsA) and hetrombopag (HETROM+CsA group) or CsA alone…
Read More » -
News
APLASTIC ANEMIA | Incidence and Clinical Management in Spain Consistent with Other Studies
The study was carried out through a multicenter, ambispective, observational approach encompassing 7 Spanish hospitals, catering to roughly 3.91 million individuals, over the span from 2010 to 2019. The research…
Read More » -
News
CLINICAL TRIALS | Positive Results Found with Transplant for Patients with Aplastic Anemia
The findings were reported in the journal Blood. The trial’s cohort included 35% of patients from underrepresented racial and/or ethnic groups, suggesting that this BMT method for patients without a…
Read More » -
News
APLASTIC ANEMIA | Eltrombopag May Increase Complete Response Rate Among Pediatric Patients
The standards of care for aplastic anemia are allogeneic hematopoietic stem cell transplantation (HSCT) or immunosuppression with horse antithymocyte globulin and cyclosporine. Early data suggest that adding ELTR to immunosuppression…
Read More »